Guide to Friedreichs Ataxia causes
Friedreich’s ataxia is a rare, inherited neurodegenerative disorder that primarily affects the nervous system and muscle coordination. Understanding the causes of Friedreich’s ataxia is crucial for grasping how the condition develops and progresses. This disease is classified as a genetic disorder, meaning it is caused by mutations in specific genes passed down from parents to their children.
The root cause of Friedreich’s ataxia lies in mutations within the FXN gene, located on chromosome 9. This gene encodes a protein called frataxin, which plays a vital role in mitochondrial function—specifically in the production of energy within cells. When the FXN gene is mutated, it results in a deficiency or malfunction of frataxin, leading to impaired mitochondrial activity. Over time, this deficit causes the degeneration of nerve tissues, especially in the spinal cord and peripheral nerves, culminating in the characteristic symptoms of ataxia, such as poor coordination, difficulty walking, and muscle weakness.
Most cases of Friedreich’s ataxia are inherited in an autosomal recessive pattern. This means a person must inherit two copies of the defective gene—one from each parent—to develop the disease. If an individual inherits only one mutated copy, they are considered a carrier and typically do not exhibit symptoms, but they can pass the mutation to their offspring. The genetic mutation responsible is an abnormal expansion of a GAA trinucleotide repeat within the FXN gene. Normally, this repeat sequence appears fewer than 40 times. However, in individuals with Friedreich’s ataxia, the GAA repeat expands to 66 or more times, disrupting the gene’s function.
The size of the GAA repeat expansion correlates with the severity and age of onset of the disease. Larger expansions tend to cause earlier and more severe symptoms. This unstable repeat expansion leads to reduced expression of frataxin, which, as mentioned earlier, is essential for mitochondrial health. The resulting energy deficiency and oxidative stress contribute to the progressive degeneration of nerve cells.
While genetics play the central role in Friedreich’s ataxia, some researchers are exploring environmental factors and other genetic modifiers that may influence disease progression, although these are not primary causes. Currently, there is no cure, and treatment focuses on managing symptoms and improving quality of life.
In summary, Friedreich’s ataxia is caused by a specific genetic mutation involving GAA trinucleotide repeat expansions in the FXN gene. This mutation leads to a deficiency in frataxin, impairing mitochondrial function and causing nerve degeneration. Understanding the genetic basis of this disorder is essential for diagnosis, genetic counseling, and future therapeutic developments.
